Breaking News Instant updates and real-time market news.

OSUR

OraSure

$10.89

0.03 (0.28%)

, GK

G&K Services

18:39
03/20/17
03/20
18:39
03/20/17
18:39

S&P announces changes to S&P SmallCap 600 index

S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: OraSure Technologies (OSUR) will replace G&K Services (GK) in the S&P SmallCap 600 effective prior to the open on Thursday, March 23. S&P 500 constituent Cintas (CTAS) is acquiring G&K Services in a deal expected to be completed soon pending final conditions. John B. Sanfilippo & Son (JBSS) will replace Popeyes Louisiana Kitchen (PLKI) in the S&P SmallCap 600 effective prior to the open on Monday, March 27. Popeyes Louisiana Kitchen is being acquired in a deal expected to be completed soon pending final conditions.

OSUR

OraSure

$10.89

0.03 (0.28%)

GK

G&K Services

CTAS

Cintas

$124.31

-0.56 (-0.45%)

JBSS

John B. Sanfilippo & Son, Inc.

$65.38

-1.3 (-1.95%)

PLKI

Acquired by QSR

$78.98

-0.01 (-0.01%)

  • 22

    Mar

  • 16

    May

OSUR OraSure
$10.89

0.03 (0.28%)

02/09/17
ADAM
02/09/17
NO CHANGE
Target $12
ADAM
Buy
OraSure set up for growth in 2017 and beyond, says Canaccord
Canaccord analyst Mark Massaro noted OraSure delivered solid Q4 results and gave good guidance for 2017. He said ongoing positive developments from its HCV business coupled with strong traction from its DNA Genotek business set it up for growth in 2017 and beyond. Massaro reiterated his Buy rating and raised his price target to $12 from $11 on OraSure shares. This note corrects an earlier version with an incorrect price target.
02/09/17
RAJA
02/09/17
UPGRADE
Target $11.25
RAJA
Outperform
OraSure upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Nicholas Jansen upgraded OraSure to Outperform with a $11.25 price target following the solid Q4 report and visible revenue catalysts over the next year that should move estimates higher. The analyst sees multiple international opportunities and tailwinds in DNA Genotek that support a more positive top-line trajectory and operating expense levers for robust underlying margin and free cash flow growth combined iwth recent restructuring actions and the wind down of legal costs. Jansen sees upside to his model in 2018 from additional HCV eradication work that is stripped out of our forecasts, new royalties tied to their ancestry.com settlement and the company's global manufacturing optimization program, which could further drive profitability.
12/20/16
KING
12/20/16
INITIATION
Target $11
KING
Buy
OraSure initiated with a Buy at CL King
CL King initiated OraSure with a Buy and a $11 price target.
12/01/16
ADAM
12/01/16
NO CHANGE
Target $11
ADAM
Buy
OraSure risk/reward remains skewed to upside, says Canaccord
Canaccord analyst Mark Massaro attended the OraSure analyst day and believes the risk/reward remains to the upside. The analyst noted the company's announcement of an exclusive Hep-C contract win with Helix and expectations for three other governments to order over 100K tests per year. Massaro reiterated his Buy rating and raised his price target to $11 from $10 on OraSure shares.
GK G&K Services

10/03/16
KEYB
10/03/16
NO CHANGE
Target $135
KEYB
Overweight
Cintas price target raised to $135 on G&K Services synergies at KeyBanc
KeyBanc analyst Joe Box raised his price target on Cintas (CTAS) to $135 from $130 as his analysis leads him to think the $130M-$140M synergy target related to the company's G&K Services (GK) deal may be conservative. While the FTC did issue a "second request" on the deal, Box continues to believe there is a high likelihood that the deal closes.
09/29/16
MSCO
09/29/16
NO CHANGE
Target $87
MSCO
Underweight
Cintas valuation appears full, says Morgan Stanley
Morgan Stanley analyst Toni Kaplan views Cintas (CTAS) valuation as full and expects shares to be pressured as organic growth slows from from a deceleration in uniform employment and waning exuberance for the G&K Services acquisition. Kaplan believes Cintas' cross selling opportunities may have reached a peak and believes the company has largely exhausted geographical expansion. The analyst rates Cintas an Underweight with an $87 price target on shares.
08/18/16
JPMS
08/18/16
DOWNGRADE
Target $97
JPMS
Neutral
G&K Services downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Andrew Steinerman downgraded G&K Services (GK) to Neutral citing the takeover by Cintas (CTAS). The analyst views the deal as positive for both companies and feels the offer price is a "healthy value."
10/06/16
BRRR
10/06/16
DOWNGRADE
BRRR
Market Perform
G&K Services downgraded to Market Perform from Outperform at Barrington
Barrington analyst Kevin Steinke downgraded G&K Services (GK) to Market Perform saying competitive bids to the price offered by Cintas (CTAS) will not emerge. The analyst views the $97.50 offer price as fair for G&K shareholders.
CTAS Cintas
$124.31

-0.56 (-0.45%)

12/23/16
JPMS
12/23/16
NO CHANGE
Target $132
JPMS
Overweight
Cintas price target raised to $132 from $125 at JPMorgan
JPMorgan analyst Andrew Steinerman raised his price target for Cintas to $132 saying the company reported "solid" Q2 results. One-time items drove the slight earnings miss, Steinerman tells investors in a post-earnings research note. He expects the company's organic growth to accelerate ad reiterates an Overweight rating on the name.
12/23/16
BARD
12/23/16
NO CHANGE
Target $137
BARD
Outperform
Cintas weakness a buying opportunity, says Baird
Baird analyst Andrew Wittmann recommended investors use any weakness in Cintas shares as a buying opportunity. He cited the company's Q2 results and said the long-term thesis remains intact as the guidance remains unchanged and the merger with GK will provide a value opportunity. Wittmann reiterated his Outperform rating and raised his price target to $137 from $135 on Cintas shares, adding that good execution, solid underlying trends, and bottoming energy pressures should offer support.
02/22/17
DBAB
02/22/17
INITIATION
Target $120
DBAB
Hold
Cintas initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Kevin McVeigh started Cintas with a Hold rating and $120 price target.
03/13/17
KEYB
03/13/17
NO CHANGE
KEYB
Cintas, UniFirst would benefit from tax reform, says KeyBanc
KeyBanc estimates that the EPS of Cintas (CTAS) and UniFirst (UNF) would be boosted by 92c and 51c, respectively, if the corporate tax cut and the border adjustment tax being considered by the Congressional GOP are passed.
JBSS John B. Sanfilippo & Son, Inc.
$65.38

-1.3 (-1.95%)

PLKI Acquired by QSR
$78.98

-0.01 (-0.01%)

02/21/17
FLTL
02/21/17
DOWNGRADE
Target $79
FLTL
Sell
Popeyes downgraded to Sell from Hold at Feltl
Feltl analyst Mark Smith downgraded Popeyes Louisiana Kitchen to Sell and raised his price target for the shares to $79 from $59 to reflect the company's takeover by Restaurant Brands (QSR).
02/22/17
OPCO
02/22/17
NO CHANGE
OPCO
Perform
Oppenheimer sees Restaurant Brands' acquisition of Popeyes as 'interesting'
Oppenheimer analyst Brian Bittner says Restaurant Brands' (QSR) "platform" for growth is again on display. In acquiring Popeyes (PLKI) for $1.8B, the company potentially gains another vehicle for unit growth, entry and a new opportunity to reduce costs, the analyst notes, adding that this is an "interesting transaction." Bittner reiterates a Perform rating on Restaurant Brands, saying it is difficult to find the next major under-appreciated theme.
02/22/17
BMOC
02/22/17
NO CHANGE
BMOC
Restaurant Brands acquisition positive, says BMO Capital
BMO Capital analyst Peter Sklar says that Restaurant Brands (RBI) can benefit from its acquisition of Popeyes (PLKI) if it can accelerate the latter company's international expansion initiative. The analyst adds that Restaurant Brands' multiple can rise if investors start to see it as a successful consolidator of quick-service chains. He raised his price target on the stock to $63 from $57 and keeps an Outperform rating on the shares.
02/22/17
FBCO
02/22/17
NO CHANGE
Target $53
FBCO
Neutral
Credit Suisse views Popeyes addition to Restaurant Brands portfolio as positive
Credit Suisse analyst Jason West says Popeyes (PLKI) addition to Restaurant Brands (QSR) portfolio is a positive. However, the analyst notes that the 7% move in the latter's shares following the news captures much of the optimism, particularly since cost cuts and accelerated store growth will take time to implement. He reiterates a Neutral rating and $53 price target on Restaurant Brands' shares.

TODAY'S FREE FLY STORIES

06:05
05/29/17
05/29
06:05
05/29/17
06:05
General news
WTI crude futures are off by 0.2% »

WTI crude futures are off…

03:10
05/29/17
05/29
03:10
05/29/17
03:10
General news
FX Update: The dollar majors have been plying narrow ranges »

FX Update: The dollar…

03:05
05/29/17
05/29
03:05
05/29/17
03:05
General news
Fed's Williams: three hikes this year still make sense. »

Fed's Williams:…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

, MJN

Mead Johnson

$89.29

0.1 (0.11%)

15:32
05/28/17
05/28
15:32
05/28/17
15:32
Conference/Events
Mead Johnson to host special shareholder meeting »

Special Shareholder…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

MJN

Mead Johnson

$89.29

0.1 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

PHH

PHH Corp.

$13.58

0.06 (0.44%)

15:25
05/28/17
05/28
15:25
05/28/17
15:25
Conference/Events
PHH Corp. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TPIV

TapImmune

$3.71

-0.03 (-0.80%)

14:37
05/28/17
05/28
14:37
05/28/17
14:37
Conference/Events
TapImmune to hold a business update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SCOR

comScore

$24.80

-0.15 (-0.60%)

14:35
05/28/17
05/28
14:35
05/28/17
14:35
Conference/Events
comScore to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BMY

Bristol-Myers

$53.97

-0.42 (-0.77%)

14:12
05/28/17
05/28
14:12
05/28/17
14:12
Conference/Events
Bristol-Myers to hold a pharmaceutical update conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

  • 24

    Sep

LOXO

Loxo Oncology

$47.44

-0.06 (-0.13%)

14:10
05/28/17
05/28
14:10
05/28/17
14:10
Conference/Events
Loxo Oncology to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

ADRO

Aduro Biotech

$10.05

-0.15 (-1.47%)

14:07
05/28/17
05/28
14:07
05/28/17
14:07
Conference/Events
Aduro Biotech to host analyst and investor meeting »

Management hosts special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

ELGX

Endologix

$4.73

-0.05 (-1.05%)

14:06
05/28/17
05/28
14:06
05/28/17
14:06
Conference/Events
Endologix to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 03

    Jun

TSRO

Tesaro

$149.11

-4.08 (-2.66%)

14:02
05/28/17
05/28
14:02
05/28/17
14:02
Conference/Events
Tesaro to hold an analyst and investor briefing »

Management hosts an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 03

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$60.35

-0.09 (-0.15%)

13:57
05/28/17
05/28
13:57
05/28/17
13:57
Conference/Events
IntercontinentalExchange to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 07

    Jun

CPA

Copa Holdings

$111.69

0.2 (0.18%)

13:48
05/28/17
05/28
13:48
05/28/17
13:48
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

CAH

Cardinal Health

$73.10

-0.34 (-0.46%)

13:31
05/28/17
05/28
13:31
05/28/17
13:31
Conference/Events
Cardinal Health to hold a meeting »

Dublin Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BPMX

BioPharmX

$0.64

0.0089 (1.41%)

13:26
05/28/17
05/28
13:26
05/28/17
13:26
Conference/Events
BioPharmX holds state of acne symposium »

Management provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.63

-0.72 (-0.89%)

13:20
05/28/17
05/28
13:20
05/28/17
13:20
Conference/Events
Novartis to hold a meeting »

Meet the Management Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

CNC

Centene

$74.57

-0.68 (-0.90%)

, MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

12:34
05/27/17
05/27
12:34
05/27/17
12:34
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$74.57

-0.68 (-0.90%)

MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

HUM

Humana

$232.25

0.02 (0.01%)

AET

Aetna

$145.57

0.34 (0.23%)

ANTM

Anthem

$183.08

1.58 (0.87%)

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

WCG

WellCare

$172.97

0.15 (0.09%)

CI

Cigna

$161.32

-0.33 (-0.20%)

BX

Blackstone

$32.58

0.11 (0.34%)

NUE

Nucor

$58.15

-0.22 (-0.38%)

X

U.S. Steel

$19.74

-0.51 (-2.52%)

STLD

Steel Dynamics

$33.71

-0.73 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 13

    Jun

  • 16

    Jun

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.